MicuRx Pharmaceuticals, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
Insights
Strong R&D Recognition MicuRx Pharmaceuticals has been recognized for its innovative research capabilities, notably with the Contezolid tablets earning the 'Top Ten Pharmaceutical Innovation Research Teams' award. This positions the company as a leader in advanced antimicrobial therapeutics, presenting opportunities to collaborate or source novel treatments for healthcare providers and institutions seeking cutting-edge solutions.
Expanding Clinical Pipeline With 15 clinical and preclinical studies being presented at ESCMID Global 2025, MicuRx demonstrates an active and expanding R&D pipeline. This ongoing development signifies the potential for future market entry of new treatments, offering sales prospects through partnerships, licensing, or direct distribution of upcoming therapeutics.
Investment & Growth Backed by substantial funding of over 107 million dollars and strategic investments from Legend Capital since 2020, MicuRx shows strong financial stability and growth potential. This stability enables the company to scale operations and adapt to emerging market demands, providing opportunities for sales in expanding markets and partnerships.
Leadership in Infectious Disease MicuRx specializes in antimicrobial therapeutics with a focus on resistant infections, exemplified by their development of MRX-5 for refractory NTM infections. This niche focus aligns well with the current demand for effective solutions against resistant pathogens, offering targeted sales opportunities to healthcare providers and hospitals.
Recognition and Awards Recent awards for innovative health products in both China and internationally highlight MicuRx’s market credibility and technological advancement. These accolades can facilitate market entry and distribution negotiations, making the company an attractive partner for health systems and distributors seeking innovative and proven therapeutics.
Similar companies to MicuRx Pharmaceuticals, Inc.
Basilea Pharmaceutica Ltd
$10M$25MEntasis Therapeutics
$1M$10MMerck
$10BPfizer
$10BParatek Pharmaceuticals
$250M$500MSpero Therapeutics
$50M$100MTetraphase Pharmaceuticals
$1M$10MMelinta Therapeutics
$25M$50MAchaogen
$25M$50M
MicuRx Pharmaceuticals, Inc. Tech Stack
MicuRx Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, Google Fonts API, yepnope.js, and more. Explore MicuRx Pharmaceuticals, Inc.'s tech stack below.
- WordPressContent Management System
- Google Fonts APIFont Scripts
- yepnope.jsJavascript Frameworks
- ModernizrJavascript Libraries
- SwiperJavascript Libraries
- LodashJavascript Libraries
- Animate.cssUI Frameworks
- PolylangWeb Platform Extensions
Media & News
MicuRx Pharmaceuticals, Inc.'s Email Address Formats
MicuRx Pharmaceuticals, Inc. uses at least 1 format(s):
| MicuRx Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@micurx.com | 89% |
| First@micurx.com | 7% |
| Last@micurx.com | 4% |
Frequently Asked Questions
Where is MicuRx Pharmaceuticals, Inc.'s headquarters located?
MicuRx Pharmaceuticals, Inc.'s main headquarters is located at 950 Tower Lane Suite 390 Foster City, California 94404 United States. The company has employees across 2 continents, including North AmericaAsia. What is MicuRx Pharmaceuticals, Inc.'s phone number?
You can contact MicuRx Pharmaceuticals, Inc.'s main corporate office by phone at +1-510-782-****
What is MicuRx Pharmaceuticals, Inc.'s official website and social media links?
MicuRx Pharmaceuticals, Inc.'s official website is micurx.com and has social profiles on LinkedInCrunchbase.How much revenue does MicuRx Pharmaceuticals, Inc. generate?
As of March 2026, MicuRx Pharmaceuticals, Inc.'s annual revenue is estimated to be $709K. What is MicuRx Pharmaceuticals, Inc.'s SIC code NAICS code?
MicuRx Pharmaceuticals, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does MicuRx Pharmaceuticals, Inc. have currently?
As of March 2026, MicuRx Pharmaceuticals, Inc. has approximately 24 employees across 2 continents, including North AmericaAsia. Key team members include Chief Medical Officer: R. A. V.President And Cfo: J. Z. L.President: Z. Y. P. D.. Explore MicuRx Pharmaceuticals, Inc.'s employee directory with LeadIQ.What industry does MicuRx Pharmaceuticals, Inc. belong to?
MicuRx Pharmaceuticals, Inc. operates in the Biotechnology Research industry. What technology does MicuRx Pharmaceuticals, Inc. use?
MicuRx Pharmaceuticals, Inc.'s tech stack includes WordPressGoogle Fonts APIyepnope.jsModernizrSwiperLodashAnimate.cssPolylang. What is MicuRx Pharmaceuticals, Inc.'s email format?
MicuRx Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@micurx.com. Find more MicuRx Pharmaceuticals, Inc. email formats with LeadIQ. How much funding has MicuRx Pharmaceuticals, Inc. raised to date?
As of March 2026, MicuRx Pharmaceuticals, Inc. has raised $107M in funding. The last funding round occurred on Dec 21, 2020 for $107M.When was MicuRx Pharmaceuticals, Inc. founded?
MicuRx Pharmaceuticals, Inc. was founded in 2007.
Company Overview
- Headquarters
- 950 Tower Lane Suite 390 Foster City, California 94404 United States
- Phone number
- +1-510-782-****
- Website
- micurx.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2007
- Employees
- 11-50
Media & News
Funding & Financials
- $107M
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
- $50M$100M
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M
Funding & Financials
- $107M
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
- $50M$100M
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M
Company Leadership
R. A. V.Chief Medical Officer
J. Z. L.President And Cfo
Z. Y. P. D.President- W. W.Head
- T. C.Medical Director
Employee Directory
- H. Y.Director
- Z. Z.Regulatory Affairs Manager
- L. D.Commercial & Corporate Development
- 卢.质量总监
- B. T.Non-Executive Directors
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
